You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 5, November 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (60)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Anemia in Uremia

Jane F. Desforges, MD

Arch Intern Med. 1970;126(5):808-811.


Abstract

Anemia is an almost invariable part of the uremic syndrome. The majority of patients have a hemolytic component which is extracorpuscular and unrelated to immune mechanisms or splenic sequestration. In some cases mechanical injury due to abnormalities of vasculature may play a role. Metabolic and mechanical abnormalities have been described in vitro, but the relation of these to hemolysis in vitro is not clear. The rate of hemolysis seldom exceeds two or three times normal. The determining factor in the anemia is relative marrow failure such that erythropoietic response to anemic anoxia is inadequate. The defect appears to reside in the failure of the diseased kidney to produce renal erythropoietic factor (REF) to activate erythropoietin.



Author Affiliations

Boston

From the Tufts Hematology Laboratory, Boston City Hospital.


Footnotes

Received for publication June 22, 1970; accepted July 27.

Read before the session entitled "Hematologic Disorders" (Allen J. Erslev, MD, chairman) of the Symposium on Uremic Toxins sponsored by the National Institute of Arthritis and Metabolic Diseases, Monterey, Calif, March 18, 1970.

Reprint requests to 818 Harrison Ave, Boston 02118 (Dr. Desforges).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Morphologic and Functional Changes of Left Ventricle in Dialyzed Patients After Treatment with Recombinant Human Erythropoietin (r-HuEPO)
Jeren-Strujic et al.
ANGIOLOGY 2000;51:131-139.
ABSTRACT  

Diagnostic Decision: The Complete Blood Count and Leukocyte Differential Count * An Approach to Their Rational Application
SHAPIRO and GREENFIELD
ANN INTERN MED 1987;106:65-74.
ABSTRACT  

Red Cell Fragmentation Syndrome With the Use of Subclavian Hemodialysis Catheters
Nand et al.
Arch Intern Med 1985;145:1421-1423.
ABSTRACT  

Effect of Parathyroidectomy on Anemia in Chronic Renal Failure
Barbour
Arch Intern Med 1979;139:889-891.
ABSTRACT  

Erythrocyte Deformability in Uremic Hemodialyzed Patients
FORMAN et al.
ANN INTERN MED 1973;79:841-843.
ABSTRACT  

Anemia of Chronic Renal Failure
S. V.
JAMA 1970;214:1880-1880.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.